:

FIRSTCLUB DOUBLES VALUATION TO $255M

INDUSTRY DESK1 MIN READ
THU, JUN 4, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

Bengaluru-based quick commerce startup FirstClub has doubled its valuation to $255 million within nine months of launch. The company has crossed 1 million orders and achieved a $50 million annualized GMV run rate.

FirstClub's rapid growth reflects the intensifying competition in India's quick commerce sector, where players like Blinkit, Zepto, and Dunzo dominate the market. The startup's $255 million valuation marks significant progress since its inception. Reaching 1 million orders in under a year demonstrates strong product-market fit and customer adoption in the crowded 10-minute delivery space. The $50 million annualized GMV run rate suggests the company is on track to build a sustainable business model. Quick commerce platforms in India have attracted substantial venture capital as they capture consumer demand for ultra-fast deliveries of groceries and essentials. FirstClub's valuation jump indicates investor confidence in the segment's growth potential despite operational challenges and capital intensity. The company now competes directly with better-funded rivals that have raised significantly larger rounds.

■ SOURCES

TechCrunch

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Colorado-based biotech startup Enveda, which uses AI to discover new drugs from natural sources, secured $311 million in Series E funding at a $2 billion valuation—double its valuation from a year ago.

2H AGOAI Desk

Modal Labs and Baseten, two platforms enabling businesses to run AI models, are in advanced funding talks that would significantly boost their valuations. The rounds reflect growing investor appetite for AI infrastructure services.

4H AGOAI Desk

Ema, an AI agent platform automating corporate processes in HR, IT, and finance, secured $77 million in Series B funding led by Creaegis. The round brings the startup's total funding to $140 million.

6H AGOAI Desk

Enveda Therapeutics raised $311 million in funding, bringing the AI biotech company's valuation to $2 billion. The capital will accelerate clinical trials for drugs derived from natural compounds.

7H AGOAI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.